Grand Junction, CO-based Avex announced in January that it has secured $7.6 million in Series A financing to fund its Q1 launch of Footbeat, an insole designed to increase circulation through cyclic pressure applied to the arch of the foot.
Orthopedic surgeon and Avex cofounder David Mayer, MD, designed and developed Footbeat to address what he identified as common patient complaints about circulation enhancement devices, ie, immobility, noise, and discomfort.
Visit footbeat.com for more information.
